TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NONMUSCLE-INVASIVE BLADDER CANCER WITH UGN-102 ± TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) COMPARED TO TURBT MONOTHERAPY: THE PHASE 3 ATLAS TRIAL

Autor: Prasad, Sandip M., Huang, William C., Shore, Neal D., Hu, Brian, Bjurlin, Marc, Brown, Gordon, Genov, Pencho, Shishkov, Dimitar, Khuskivadze, Alexandre, Ganev, Tosho, Marchev, Dobri, Orlov, Igor, Kopyltsov, Evgeny, Zubarev, Vadim, Nosov, Alexander, Komlev, Dmitrii, Burger, Brent, Raju, Sunil, Meads, Andrew, Schoenberg, Mark
Zdroj: In Urologic Oncology: Seminars and Original Investigations March 2024 42 Supplement:S57-S57
Databáze: ScienceDirect
Externí odkaz: